Now here’s a drug with a built-in market: a two-fer, in fact. Rimonabant “is the first of a new class of drugs that act to block the brain’s endocannabinoid system, thought to be responsible for a range of cravings, including those for food and nicotine.”
So you can pop these pills, quit smoking and lose weight at the same time. What’s not to like?
Caution: the proprietor makes no representation as to the validity of this drug’s properties or its maker’s claims.
Now you’re screwed. When blogged this story a couple of months ago, I enough Google search traffic to bring my site to a crawl for about a week. And the comments…
Oh boy. Er, thanks for the heads-up, Al. 😉 That’ll teach me to mix work (reading biotech journals) and blogging.
ooohhhhhh …
Yes, but will they help me stop watching crappy TV shows?
(coughSmallvillecoughcough)
If Senator Kerry is elected and reinstates funding for stem-cell research, Christina, it might happen! 😉